US equities |
SPCX $163.37 ▲+1.74% TSLA $386.74 ▲+3.13% MU $1,035.47 ▼-0.04% NVDA $230.78 ▲+0.13% AAPL $333.35 ▼-2.08% AMD $614.92 ▼-0.93% SNDK $1,617.81 ▲+0.52% LITE $1,122.23 ▲+7.02%
FinancialContent

Latest News about Phase 2

Recent news which mentions Phase 2

Marker Therapeutics Secures $13.1M Grant To Support MultiTAA Cell Therapy Trial
Tickers MRKR
Tags Penny Stocks Market News News
From Benzinga
Paratek's Antibiotic Gets FDA Orphan Drug Tag For Lung Infection
Tickers PRTK
Tags General Benzinga Orphan Drug Designation
From Benzinga
Galecto Starts Dosing In Mid-Stage Myelofibrosis Trial
Tickers GLTO
Tags myelofibrosis GLTO Phase 2
From Benzinga
DMC Recommends Biophytis Continue Sarconeos COVID-19 Study
Tickers BPTS
Tags General BPTS Biotech
From Benzinga